tk88 bet

Hanoi Eye Hospital, Novartis launch glaucoma patient class

The Hanoi Eye Hospital and Novartis Vietnam launched the Glaucoma Hybrid Patient Class, a hybrid patient education model combining face-to-face and online platforms, on October 24.
Hanoi Eye Hospital, Novartis launch glaucoma patient class ảnh 1Illustrative image (Photo: Hanoi Eye Hospital)
Hanoi (VNS/VNA) - The Hanoi Eye Hospital and Novartis Vietnamlaunched the Glaucoma Hybrid Patient Class, a hybrid patient education modelcombining face-to-face and online platforms, on October 24.

Different from traditional patient classes organised face to face in hospitals,this hybrid model will make it convenient for more patients to attend and helpthem with increased awareness and compliance in the treatment of glaucoma,which is known as “the silent thief of vision” causing irreversible loss ofvision and is the second leading cause of blindness in Vietnam and in theworld.

The programme will take place at three leading eye hospitals in Vietnam,including the Hanoi Eye Hospital, Da Nang Eye Hospital and the Ho Chi Minh City EyeHospital, from October to December 2022.

To optimise the effectiveness in raising awareness about glaucoma for patientsand their caregivers, each hybrid patient class is implemented simultaneouslyon two platforms: live at the hospital and online through digital platforms.

At the hospital, the model provides patients with information in the form ofinfographics about glaucoma, clearly showing the prevalence and risk ofglaucoma.

Through digital platforms such as Zalo, Youtube, and the website of Hanoi EyeHospital, the programme will be deployed to maximise the efficiency ofaccessing information and knowledge by patients.

“With the combination of both face-to-face and online platforms supported bydigital technology, I believe this is a very effective health education patientclass model that can help patients and caregivers who cannot go to the hospitalstill have access to health information, medical advice, and answers toGlaucoma-related questions,” said Hanoi Eye Hospital director Nguyen Xuan Tinh.

In Vietnam, according to a survey conducted by the National Eye Institute andAtlantic Philanthropies in 16 provinces in 2007, 24,800 people were blind inboth eyes due to glaucoma. In 2015, there were 13,160 people blind due toglaucoma.

According to statistics from the World Health Organization (WHO), glaucoma isthe second leading cause of blindness in the world. In 2020, the number ofpeople (ages 40-80) with glaucoma in the world is about 79.6 million, which ispredicted to increase to 111.8 million by 2040, of which Asian glaucomapatients account for 47%. In developed countries, about 50% of people withglaucoma do not know they have the disease and do not go to the doctor.Meanwhile, in developing countries, this number can increase to up to 90%./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

꧋ Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

ꦍ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

ꦍ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|